http://www.fresenius.com en-us Thu, 20 Feb 2020 00:00:00 +0100 Thu, 20 Feb 2020 00:00:00 +0100 Thu, 20 Feb 2020 08:00:00 +0100 <![CDATA[Fresenius Kabi and Vifor Pharma create joint venture in China for i.v. iron portfolio ]]> Fresenius Kabi and Vifor Pharma have formed a joint venture in China to provide patients access to vital blood management treatment. It will combine Vifor Pharma’s leading intravenous drug portfolio for the treatment of iron deficiency with Fresenius Kabi’s strong and long-year presence in the market to benefit both patients and the healthcare system in China. The joint venture will focus on marketing, market access and medical affairs activities whereas Fresenius Kabi will be fully responsible for the commercialization of the intravenous iron portfolio. The joint company will be 55% owned by Vifor Pharma and 45% by Fresenius Kabi. Financial terms were not disclosed.

]]>
Thu, 20 Feb 2020 08:00:00 +0100 <![CDATA[Fresenius reports 16th consecutive record year – After significant investments in 2019, company expects healthy growth in 2020 and confirms medium-term growth targets]]> Stephan Sturm, CEO of Fresenius, said: “2019 was a good year for Fresenius. A year of challenges, but also of many successes. We have treated even more patients, launched new products, and increased our sales to more than 35 billion euros. (...)"

]]>
Wed, 19 Feb 2020 08:00:00 +0100 <![CDATA[Fresenius Helios acquires first hospital in Bogotá, continuing expansion in Colombia’s private hospital market]]> Quirónsalud, the largest private hospital group in Spain and part of Fresenius Helios, has signed an agreement to acquire Clínica de la Mujer in Bogotá, further expanding the company’s presence in Colombia’s attractive private hospital market.

]]>
Wed, 19 Feb 2020 08:00:00 +0100 <![CDATA[Fresenius Medical Care achieves 2019 guidance and confirms 2020 outlook of sustainable, profitable growth]]> Rice Powell, Chief Executive Officer of Fresenius Medical Care, said: “2019 was a successful year for Fresenius Medical Care. We achieved our revenue and net income targets and are therefore proposing our 23rd consecutive dividend increase. (...)"
 

]]>
Fri, 24 Jan 2020 08:00:00 +0100 <![CDATA[Fresenius Kabi inaugurates €30 million expansion of transfusion and apheresis disposables plant in Dominican Republic]]> Top government and company officials joined local executives and employees as Fresenius Kabi inaugurated yesterday the major expansion of the company’s production site in the Dominican Republic. 

]]>
Tue, 21 Jan 2020 08:00:00 +0100 <![CDATA[Fresenius Kabi enters into joint venture to advance new cell and gene therapies]]> Fresenius Kabi, Bio-Techne and Wilson Wolf have formed a new joint venture to support researchers and biopharmaceutical companies in the field of cell and gene therapy. The joint venture is owned equally by the three partners and will focus on providing scalable manufacturing technologies and processes needed to develop and commercialize new cell and gene therapies. No financial terms were disclosed.

]]>
Thu, 16 Jan 2020 08:00:00 +0100 <![CDATA[Fresenius Helios trains doctors in antibiotics management]]> Fresenius Helios has started training experts in antibiotics management to combat the growing threat from multi-resistant bacteria. In the coming years, more than 600 doctors will be trained at the company’s 86 hospitals in Germany on the correct way to handle antibiotics. These doctors will raise awareness of the problem among colleagues and be available for consultations with them. In addition, Fresenius Helios is introducing a system under which each hospital will report on its antibiotics usage.

]]>
Tue, 07 Jan 2020 08:00:00 +0100 <![CDATA[Fresenius successfully places bonds with a volume of 750 million euros]]> Mon, 23 Dec 2019 08:00:00 +0100 <![CDATA[Fresenius Helios acquires leading private hospital in Colombia]]> Quirónsalud, the largest private hospital group in Spain and part of Fresenius Helios, has signed an agreement to acquire Centro Médico Imbanaco (CMI) in Cali, further expanding the company’s presence in Colombia’s attractive private hospital market.

]]>
Thu, 19 Dec 2019 08:00:00 +0100 <![CDATA[Dr. Karl Schneider retiring from Supervisory Board of Fresenius Management SE and named honorary member – Wolfgang Kirsch to join at new year]]> Dr. Karl Schneider, a longtime member of the Supervisory Board of Fresenius, has decided to retire from the Supervisory Board of Fresenius Management SE on December 31, 2019.

]]>
Tue, 10 Dec 2019 08:00:00 +0100 <![CDATA[Fresenius Helios awards new innovation prize]]> Fresenius Helios has awarded its inaugural Helios-Pro-Inno Prize for outstanding innovation and projects in patient care and hospital management. Three different projects at Helios Wuppertal, Helios Berlin-Buch and Helios Bad Saarow hospitals in Germany were honored: A color and lighting concept that demonstrably improved the well-being of intensive care patients and even reduced their need for certain medications; the appointment of a “Feel Good Manager” for resolving employees’ problems in the workplace, and an antibiotics reporting system developed in response to the growing threat from multi-resistant bacteria. A jury of eight members, from different occupational groups, chose the Helios-Pro-Inno Prize winners from more than 70 entries.

]]>
Wed, 20 Nov 2019 08:00:00 +0100 <![CDATA[Fresenius Medical Care places bonds with a volume of 1.75 billion euros]]> Fresenius Medical Care today successfully placed bonds in three tranches with an aggregate volume of €1.75 billion.

]]>
Tue, 12 Nov 2019 08:00:00 +0100 <![CDATA[Fresenius Vamed completes main university hospital building in Lübeck ]]> After four years of construction Fresenius Vamed has completed the new main building at University Hospital Schleswig-Holstein (UKSH) in Lübeck. Following the opening in August of the new main building at the UKSH’s other location, in Kiel, the modernization of Germany’s second-largest university hospital is now largely complete. In addition to the new construction and the comprehensive renovation of the two university hospital locations, the project includes their technical management through 2044. With a total volume of €1.7 billion, the UKSH modernization is currently the biggest public-private partnership project in Europe’s healthcare sector.

]]>
Tue, 05 Nov 2019 08:00:00 +0100 <![CDATA[Fresenius Vamed wins awards for spa and wellness facilities]]> VAMED Vitality World has been named the “World’s Best Thermal Spa & Medical Wellness Operator 2019” at the World Spa Awards. Four VAMED Vitality World facilities – Geinberg5 Private Spa Villas, St. Martins Therme & Lodge, Therme Laa Hotel & Spa and la pura women’s health resort – also won in their individual categories. VAMED Vitality World, part of Fresenius Vamed, operates a total of nine spa and health resorts in Austria.

]]>
Mon, 04 Nov 2019 08:00:00 +0100 <![CDATA[Fresenius Medical Care launches connected health platform in North America]]> Fresenius Medical Care North America (FMCNA) has launched its new connected health platform called TheHub. The platform is comprised of three integrated applications - PatientHub, CareTeamHub and ProviderHub - that enable patients, care teams, and providers to better collaborate and monitor patient treatments. Research by FMCNA indicates that patients who actively use these connected health solutions have a 20 percent lower risk of hospitalization, higher transplantation rates, and stay on the modality longer.

]]>
Mon, 04 Nov 2019 08:00:00 +0100 <![CDATA[Fresenius Helios acquires medical diagnostics provider in Colombia]]> Quirónsalud, Spain’s largest private hospital group and part of Fresenius Helios, has acquired CediMed, a leading medical diagnostics group in Colombia. CediMed operates seven centrally located centers in Medellin.

]]>
Fri, 01 Nov 2019 08:00:00 +0100 <![CDATA[Fresenius Medical Care North America achieves strongest quality ratings to date]]> Fresenius Medical Care North America continues to improve clinical quality as measured by the U.S. government’s Five-Star Rating System. More than 94 percent of the company’s dialysis centers were rated three stars and above for clinical quality, with a total of 762 centers achieving the highest five star rating, up from 658 last year. The Centers for Medicare and Medicaid Services (CMS) assigns one to five stars to each dialysis center annually based on a series of measurements around clinical performance and patient outcomes.

]]>
Tue, 29 Oct 2019 08:00:00 +0100 <![CDATA[Fresenius Medical Care appoints Dr. Frank Maddux to Management Board, makes Global Chief Medical Officer a board position]]> Fresenius Medical Care, the world’s leading provider of dialysis products and services, announced today the appointment of Dr. Frank Maddux, 61, the company’s Global Chief Medical Officer, to the Management Board. He will start in his new position on January 1, 2020.

]]>
Tue, 29 Oct 2019 08:00:00 +0100 <![CDATA[Fresenius confirms guidance after solid third quarter]]> Stephan Sturm, CEO of Fresenius, said: “Our businesses developed solidly in the third quarter, keeping Fresenius on track to deliver the results that we promised earlier this year. We posted strong organic growth across all four business segments. Our investments in future growth are proceeding as planned. (...)"

]]>
Tue, 29 Oct 2019 08:00:00 +0100 <![CDATA[Fresenius Medical Care again delivers strong organic growth in the third quarter]]> Rice Powell, Chief Executive Officer of Fresenius Medical Care, said: “In the third quarter Fresenius Medical Care once again achieved stable, healthy growth. Our underlying business continues to develop according to plan and we are working successfully to provide even more patients with ever better and more individualized treatment options. (...)"

]]>